Document is current
Any future updates will be listed below
-
Authors
Alifrangis, Constantine
McGovern, Ursula
Freeman, Alex
Powles, Thomas
Linch, Mark
- License Information
-
More Information
Article History
Accepted: 29 May 2019
First Online: 9 July 2019
Competing interests
: M.L. has received research funding from Bristol-Myers Squibb, AstraZeneca/MedImmune and Astellas, and has received consulting fees from Janssen Pharmaceuticals. T.P. receives research funding from AstraZeneca/MedImmune, Genentech/Roche and Novartis, and consulting fees from Genentech/Roche, Pfizer, GlaxoSmithKline and Merck. The other authors declare no competing interests.
